You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

In-Basket message

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Building Electronic Tools To Enhance and Reinforce

Completed
  • Heart Failure
  • Heart Failure With Reduced Ejection Fraction
  • Best Practice Alert (BPA)
  • In-Basket Message
  • New York, New York
    NYU Langone Health
Oct 27, 2022

Heart Failure, Heart Failure With Reduced Ejection Fraction Trial in New York (Best Practice Alert (BPA), In-Basket Message)

Completed
  • Heart Failure
  • Heart Failure With Reduced Ejection Fraction
  • Best Practice Alert (BPA)
  • In-Basket Message
  • New York, New York
    NYU Langone Health
Jan 12, 2023

Balloon Catheter vs. Basket Catheter in Pancreatic Duct Stone

Completed
  • Chronic Pancreatitis
  • basket catheter
  • balloon catheter
  • Shanghai, Shanghai, China
    Changhai Hospital
May 24, 2023

Biliary Obstruction Trial in Kafr Ash Shaykh (dormia basket, Extraction biliary ballon)

Completed
  • Biliary Obstruction
  • dormia basket
  • Extraction biliary ballon
  • Kafr Ash Shaykh, Egypt
    Mohamed Hussien Ahmed
Nov 29, 2022

Cancer, Solid Tumor Trial in San Francisco (Personalized Synthetic Long Peptide Vaccine)

Enrolling by invitation
  • Cancer
  • Solid Tumor
  • Personalized Synthetic Long Peptide Vaccine
  • San Francisco, California
    Quest Clinical Research
Feb 20, 2023

Pancreatitis, Chronic, Pancreatic Duct Stone Trial in Shanghai (Basket group, Balloon group)

Enrolling by invitation
  • Pancreatitis, Chronic
  • Pancreatic Duct Stone
  • Basket group
  • Balloon group
  • Shanghai, China
    Changhai Hospital
Sep 13, 2022

Colon Disease, Educational Problems Trial in Amasya (Education Group, Text Message Group)

Recruiting
  • Colon Disease
  • Educational Problems
  • Education Group
  • Text Message Group
  • Amasya, Turkey
    Amasya U
Oct 3, 2023

Fluorocholine PET/CT Trial (18F-fluorocholine PET/CT.)

Not yet recruiting
  • Fluorocholine PET/CT
  • 18F-fluorocholine PET/CT.
  • (no location specified)
Oct 24, 2022

Smoking, Smoking Cessation Trial in Madison (Rate Emotional Response, Rate Impact of Message)

Completed
  • Smoking
  • Smoking Cessation
  • Rate Emotional Response
  • Rate Impact of Message
  • Madison, Wisconsin
    University of Wisconsin
Apr 18, 2023

Diabetic Foot Ulcer Trial in Taoyuan City (customized standardized educational program sent by LINE software.)

Recruiting
  • Diabetic Foot Ulcer
  • customized standardized educational program sent by LINE software.
  • Taoyuan City, Taiwan
    Chang Gung Memorial Hospital
Sep 18, 2023

LGMD Trial (GenPHSat injection (Safety), GenPHSat injection (Efficacy), Muscle Biopsy (Safety))

Not yet recruiting
  • LGMD
  • GenPHSat injection (Safety)
  • +2 more
  • (no location specified)
Oct 20, 2022

Medication Adherence Trial in Antalya (reminder text message)

Completed
  • Medication Adherence
  • reminder text message
  • Antalya, Konyaalti, Turkey
    Akdeniz University
Aug 25, 2023

Efficacy Trial in Seoul (Oral sotorasib + IV Panitumumab)

Active, not recruiting
  • Efficacy
  • Oral sotorasib + IV Panitumumab
  • Seoul, Korea, Republic of
    Korea University Anam Hospital
Aug 14, 2023

Metastatic Cancer, HER2 Gene Mutation Trial in Seoul (Neratinib Maleate)

Active, not recruiting
  • Metastatic Cancer
  • HER2 Gene Mutation
  • Neratinib Maleate
  • Seoul, Korea, Republic of
    Korea university Guro hospital
Oct 18, 2023

Health Communication, Smoking, Smoking, Tobacco Trial (Reduced nicotine message exposure, Modified risk message exposure,

Not yet recruiting
  • Health Communication
  • +4 more
  • Reduced nicotine message exposure
  • +3 more
  • (no location specified)
Aug 16, 2022

Head and Neck Tumors, MSI-H Cancer, Melanoma Trial (Tiragolumab and atezolizumab)

Not yet recruiting
  • Head and Neck Neoplasms
  • +2 more
  • Tiragolumab and atezolizumab
  • (no location specified)
Aug 1, 2022

COVID-19 Trial in Philadelphia (COVID Booster text messages)

Enrolling by invitation
  • COVID-19
  • COVID Booster text messages
  • Philadelphia, Pennsylvania
    University of Pennsylvania
Jan 3, 2023

mHealth Message on Metabolic Syndrome and Bone Loss of HIV

Not yet recruiting
  • Hiv
    • (no location specified)
    Sep 1, 2023

    Anatomic Stage IV Breast Cancer AJCC v8, Breast Carcinoma, HER2-Negative Breast Carcinoma Trial (other, procedure, behavioral)

    Not yet recruiting
    • Anatomic Stage IV Breast Cancer AJCC v8
    • +3 more
    • Electronic Health Record Review
    • +6 more
    • (no location specified)
    Oct 27, 2023

    COVID-19 Trial in Philadelphia (COVID Booster text messages)

    Enrolling by invitation
    • COVID-19
    • COVID Booster text messages
    • Philadelphia, Pennsylvania
      University of Pennsylvania
    Jan 3, 2023

    Cancer, Cancer Metastatic, BRAF V600E Trial in Indianapolis (Abemaciclib, LY3214996)

    Recruiting
    • Cancer
    • +6 more
    • Indianapolis, Indiana
      Indiana University Hospital / IU Simon Cancer Center
    Jan 12, 2023

    Rheumatoid Arthritis, Diabetic Neuropathy, Fibromyalgia Trial in New York (DiNaMo Study App, Placebo App)

    Recruiting
    • Rheumatoid Arthritis
    • +3 more
    • DiNaMo Study App
    • Placebo App
    • New York, New York
      Click Therapeutics
    Oct 14, 2022

    Solid Tumor, Adult Trial in San Francisco (Leronlimab)

    Active, not recruiting
    • Solid Tumor, Adult
    • San Francisco, California
      Quest Clinical Research
    Jun 30, 2022

    Advanced Solid Tumors Harboring NTRK Fusion, Primary CNS Tumors Harboring NTRK Fusion Trial in Guangzhou (ICP-723)

    Recruiting
    • Advanced Solid Tumors Harboring NTRK Fusion
    • Primary Central Nervous System Tumors Harboring NTRK Fusion
    • Guangzhou, Guangdong, China
      Sun Yat-Sen University Cancer Center
    Feb 16, 2023

    Stroke, Caregiver Burden, Mobile Phone Use Trial in Hong Kong (iCBT-based EMI)

    Not yet recruiting
    • Stroke
    • +2 more
    • iCBT-based EMI
    • Hong Kong, Hong Kong
    • +4 more
    Jun 7, 2023